In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Sorry there are no matching results for that search term
Adverse reactions attributed to entire drug class 'Statin (see HMG-CoA reductase inhibitor)'
Please login to view adverse reactions.
Angioedema (formerly named angioneurotic edema)
- (2019): Visconti MJ+, Int J Dermatol Dec, Epub ahead of print [REVIEW]
Lupus erythematosus (subacute cutaneous lupus erythematosus (SCLE))
- (9999): Laurinaviciene R+, Eur J Dermatol Oct, Epub ahead of print
- (2012): Massay RJ+, West Indian Med J 61(7), 743 (3 cases)
- (2017): Kim H+, Basic Clin Pharmacol Toxicol 121(5), 4095%
- (2019): Tan B+, Expert Rev Clin Pharmacol Apr, Epub ahead of print [REVIEW]
- (2017): Mulchandani R+, Acta Cardiol Nov, Epub ahead of print~20%
- (2017): Mulchandani R+, Acta Cardiol Nov, Epub ahead of print31%
- (2014): Tuccori M+, CNS Drugs 28(3), 249
- (2017): Mulchandani R+, Acta Cardiol Nov, Epub ahead of print31%
- (2016): Oscanoa Espinoza TJ+, Rev Fac Cien Med Univ Nac Cordoba (Spanish) 73(4), 263 [REVIEW]
- (2015): Dobrzynski JM+, Curr Atheroscler Rep 17(2), 477
Dyspepsia / functional dyspepsia (indigestion) (see also gastroparesis)
- (2017): Kim H+, Basic Clin Pharmacol Toxicol 121(5), 4096%
- (2020): Qasim Agha O+, BMJ Case Rep 13(2), e232391 (1 case)
Hepatotoxicity / liver injury / acute liver injury / drug-induced liver injury (DILI)
- (2020): Meurer L+, Clin Liver Dis 24(1), 107 [REVIEW]
- (2017): Naiqiong W+, Med Sci Monit 23, 5760
- (2016): Wang LY+, Br J Clin Pharmacol 82(3), 823
- (2015): Bjornsson ES, Arch Toxicol 89(3), 327
- (2015): Dobrzynski JM+, Curr Atheroscler Rep 17(2), 477
- (2014): Berta E+, Pharmazie 69(6), 42039%
Pancreatitis / acute pancreatitis
- (2015): Kuoppala J+, Pharmacoepidemiol Drug Saf 24(10), 1085
- (2017): Millan J+, Clin Investig Arterioscler (Spanish) 29(1), 743%
- (2017): Mulchandani R+, Acta Cardiol Nov, Epub ahead of print~20%
- (2017): Millan J+, Clin Investig Arterioscler (Spanish) 29(1), 728%
Myalgia/Myositis/Myopathy/Myotoxicity
- (2021): Alzueta N+, Eur J Hosp Pharm 28(2), 115-117 (1 case)
- (2020): Kee PS+, Front Genet Oct (e-Collection) [REVIEW]
- (2020): Madgula AS+, Cureus 12(4), e7500 (1 case)
- (2020): Mirlesse N+, Age Ageing Mar, Epub ahead of print (1 case) (autoimmune myopathy)
- (2020): Nikolic D+, Expert Opin Drug Saf Apr, Epub ahead of print [REVIEW]
- (2020): Qasim Agha O+, BMJ Case Rep 13(2), e232391 (1 case)
- (2019): Berent T+, Atheroscler Suppl Aug, Epub ahead of print
- (2018): Kosinski C+, Rev Med Suisse (French) 14(596), 462 [REVIEW]
- (2018): Wooten JM, South Med J 111(1), 39 [REVIEW]
- (2017): Guemara R+, Rev Med Suisse (French) 13(562), 1013
- (2017): Kim H+, Basic Clin Pharmacol Toxicol 121(5), 40912%
- (2017): Millan J+, Clin Investig Arterioscler (Spanish) 29(1), 778%
- (2017): Mulchandani R+, Acta Cardiol Nov, Epub ahead of print32–47%
- (2017): Nazir S+, J Clin Rheumatol 23(3), 149 [REVIEW] (autoimmune myopathy)
- (2016): Pedro-Botet J+, Expert Opin Drug Saf 15(12), 158378%
- (2015): Dobrzynski JM+, Curr Atheroscler Rep 17(2), 477
- (2014): Ahmad Z, Am J Cardiol 113(10), 1765
- (2014): Berta E+, Pharmazie 69(6), 42055%
- (2014): Brygger L+, Expert Opin Drug Saf Sep, Epub ahead of print
- (2014): Ganga HV+, Am Heart J 168(1), 6 [REVIEW]
- (2014): Jiang Y+, Zhonghua Xin Xue Guan Bing Za Zhi (Chinese) 42(11), 905
- (2013): Mohassel P+, Muscle Nerve 48(4), 477 [REVIEW] (autoimmune myopathy)
- (2011): Abd TT+, Expert Opin Drug Saf 10(3), 373 [REVIEW]
- (2021): Safitri N+, Drug Healthc Patient Saf 13, 211-219 [REVIEW]
- (2018): Kosinski C+, Rev Med Suisse (French) 14(596), 462 [REVIEW]
- (2017): Millan J+, Clin Investig Arterioscler (Spanish) 29(1), 73%
- (2016): Ambapkar SN+, J Assoc Physicians India 64(7), 93
- (2016): Oscanoa Espinoza TJ+, Rev Fac Cien Med Univ Nac Cordoba (Spanish) 73(4), 263 [REVIEW]
- (2016): Pedro-Botet J+, Expert Opin Drug Saf 15(12), 15833%
- (2015): Simons JE+, J Clin Lipidol 9(4), 594
- (2014): Jiang Y+, Zhonghua Xin Xue Guan Bing Za Zhi (Chinese) 42(11), 905
- (2012): Hoffman KB+, PLoS One 7(8), e42866
Statin-induced necrotizing autoimmune myopathy
- (2022): Ganta N+, Cureus 14(2), e22273 (1 case / male)
- (2021): Alzueta N+, Eur J Hosp Pharm 28(2), 115-117
- (2021): Fidalgo C+, Acta Med Port Sep, Online ahead of print (2 cases)
- (2020): Huda SA+, Proc (Bayl Univ Med Cent) 34(1), 185-186 (1 case / male)
- (2020): Meyer A+, Arthritis Res Ther 22(1), 5 (55 cases)
- (2013): Hamann PD+, Autoimmun Rev 12(12), 1177-81 [REVIEW]
- (2016): Knobloch K, Adv Exp Med Biol 920, 229
- (2014): Wise SJ+, Can J Cardiol 30(12), 1613
- (2013): Lei JY+, Zhonghua Yan Ke Za Zhi (Chinese) 49(5), 468 [REVIEW]
- (2015): Mizranita V+, Int J Clin Pharm 37(5), 844
- (2015): Mizranita V+, Int J Clin Pharm 37(5), 844
Adverse effects / adverse reactions
- (2021): Lin JL+, J Atheroscler Thromb Sep, Online ahead of print
- (2021): Yee J+, J Pers Med 11(7), 677 [REVIEW]
- (2020): Conte C+, Fundam Clin Pharmacol Feb, Epub ahead of print [REVIEW]
- (2020): Mulchandani R+, Expert Opin Drug Saf Jul, Online ahead of print [REVIEW]
- (2020): Thomas JP+, Eur J Clin Pharmacol Jul, Online ahead of print [REVIEW]
- (2019): Bae HJ+, Korean J Intern Med Aug, Epub ahead of print12%
- (2018): Bellosta S+, Expert Opin Drug Saf 17(1), 25 [REVIEW] (from drug interactions)
- (2017): Atonstad S, Tidsskr Nor Laegeforen (Norwegian) 137(1), 36
- (2015): de Keyser CE+, Eur J Endocrinol 173(2), 155 (low testosterone levels in males)
- (2014): Berta E+, Pharmazie 69(6), 42024% (gastrointestinal)
- (2014): Desai CS+, BMJ 349, g3743 [REVIEW]
